Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.

Onco Targets Ther · 2015 · PMC4335610 · PMID 25709477

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

The survival time showed a slight trend towards superiority of S+CT+RT over CT+RT or S+CT, although these differences were not statistically significant because of the small sample ( P =0.73) ( Figure 1D ).

also in 2,443 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.